SESN2 and cardiac hypertrophy: As reported, in a phenylephrine-induced hypertrophy model, SESN2 expression was decreased in the process of cardiac hypertrophy, and SESN2 retarded the cardiomyocyte hypertrophy process by inhibiting ERK1/2 signaling (33).